Radiopharm Theranostics Ltd ADR (RADX)

$16.19 +10.59 (189.11%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 10,245
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It develops RAD 204, a programmed death-ligand 1 (PD-L1) for the treatment of non-small cell lung cancer (NSCLC); RAD 202, a human epidermal growth factor receptor 2 (HER2) to treat breast cancer and other solid tumors; and RAD 301, a diagnostic radiopharmaceutical targeting avß6 integrin in pancreatic ductal adenocarcin...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
Address:
62 Lygon Street, Level 3, Carlton, Australia
SWCtrader
SWCtrader Jul. 13 at 1:04 AM
$RADX can you buy this on fidelity? I want to enter big on monday
1 · Reply
RadioIsotope25
RadioIsotope25 Jul. 11 at 8:28 PM
$RADX Illegal marking close down.
0 · Reply
RadioIsotope25
RadioIsotope25 Jul. 11 at 5:53 PM
$RADX Lutetium 177 is a blockbuster isotope fda approved for prostate cancer. Radiopharm Theranostics has 2 therapeutics using it targeting Breast and Lung cancer- they are backed by the Tesla of Radiopharmaceutical’s Lantheus having invested in January upping their position to 12% with most recent buy at the currency adjusted price of $11.75… https://www.facebook.com/share/v/1Huo4Ed5J1/?mibextid=wwXIfr $LNTH $CATX $NNE
0 · Reply
RadioIsotope25
RadioIsotope25 Jul. 10 at 11:16 PM
$RADX M&A https://m.youtube.com/watch?v=LYvuDsBfe58&pp=ygUccmFkaW9waGFybWFjZXV0aWNhbHMgbWVyZ2Vycw%3D%3D $CATX $CLRB
0 · Reply
RadioIsotope25
RadioIsotope25 Jul. 10 at 7:22 PM
$RADX Lantheus is moving back up nicely. $LNTH
0 · Reply
RadioIsotope25
RadioIsotope25 Jul. 10 at 5:05 PM
$RADX No size on Level2
0 · Reply
RadioIsotope25
RadioIsotope25 Jul. 10 at 4:09 PM
$RADX Only 4K borrow could explode at any time in Radiopharm Theranostics $MP $NNE $MNPR
0 · Reply
PaulLaurent
PaulLaurent Jul. 9 at 8:26 PM
📊🔥 Top Gainers Update 💰🚨 $KLG $IGC $ALUR $MFI $RADX
0 · Reply
e17
e17 Jul. 9 at 8:15 PM
$RADX Not in any rush but could slap through a few trades and be at 8+ pretty fast. 👍
0 · Reply
RadioIsotope25
RadioIsotope25 Jul. 9 at 3:28 PM
$RADX Her2 and H7-H3 report free https://beacon-intelligence.com/market-reports/brain-cancer-landscape/?mkt_tok=MzU1LURPUy00MjkAAAGbjryx37yWPQ31WfbGUNm0vue1Gt5I-HLGbtg3769YtxK8_pbhyrRuLyMKwed1z38Wy-p5tPt8LJrXvKazz__vjpuO42l4TRz9dvRbYDzf5VnbkNw
0 · Reply
Latest News on RADX
No data available.
SWCtrader
SWCtrader Jul. 13 at 1:04 AM
$RADX can you buy this on fidelity? I want to enter big on monday
1 · Reply
RadioIsotope25
RadioIsotope25 Jul. 11 at 8:28 PM
$RADX Illegal marking close down.
0 · Reply
RadioIsotope25
RadioIsotope25 Jul. 11 at 5:53 PM
$RADX Lutetium 177 is a blockbuster isotope fda approved for prostate cancer. Radiopharm Theranostics has 2 therapeutics using it targeting Breast and Lung cancer- they are backed by the Tesla of Radiopharmaceutical’s Lantheus having invested in January upping their position to 12% with most recent buy at the currency adjusted price of $11.75… https://www.facebook.com/share/v/1Huo4Ed5J1/?mibextid=wwXIfr $LNTH $CATX $NNE
0 · Reply
RadioIsotope25
RadioIsotope25 Jul. 10 at 11:16 PM
$RADX M&A https://m.youtube.com/watch?v=LYvuDsBfe58&pp=ygUccmFkaW9waGFybWFjZXV0aWNhbHMgbWVyZ2Vycw%3D%3D $CATX $CLRB
0 · Reply
RadioIsotope25
RadioIsotope25 Jul. 10 at 7:22 PM
$RADX Lantheus is moving back up nicely. $LNTH
0 · Reply
RadioIsotope25
RadioIsotope25 Jul. 10 at 5:05 PM
$RADX No size on Level2
0 · Reply
RadioIsotope25
RadioIsotope25 Jul. 10 at 4:09 PM
$RADX Only 4K borrow could explode at any time in Radiopharm Theranostics $MP $NNE $MNPR
0 · Reply
PaulLaurent
PaulLaurent Jul. 9 at 8:26 PM
📊🔥 Top Gainers Update 💰🚨 $KLG $IGC $ALUR $MFI $RADX
0 · Reply
e17
e17 Jul. 9 at 8:15 PM
$RADX Not in any rush but could slap through a few trades and be at 8+ pretty fast. 👍
0 · Reply
RadioIsotope25
RadioIsotope25 Jul. 9 at 3:28 PM
$RADX Her2 and H7-H3 report free https://beacon-intelligence.com/market-reports/brain-cancer-landscape/?mkt_tok=MzU1LURPUy00MjkAAAGbjryx37yWPQ31WfbGUNm0vue1Gt5I-HLGbtg3769YtxK8_pbhyrRuLyMKwed1z38Wy-p5tPt8LJrXvKazz__vjpuO42l4TRz9dvRbYDzf5VnbkNw
0 · Reply
RadioIsotope25
RadioIsotope25 Jul. 8 at 6:42 PM
$RADX Trading at $4.00 And that’s a $7.70 discount to what Lantheus just paid in January. https://m.youtube.com/watch?v=OjzgnRS7b98 $MNPR $NNE
0 · Reply
RadioIsotope25
RadioIsotope25 Jul. 7 at 6:47 PM
Nice research report from Jones on Prime saying it’s an acquisition target to get stock explosive today. Same firm sees great value in Radiopharm Theranostics too. $RADX $PRME
1 · Reply
RadioIsotope25
RadioIsotope25 Jul. 7 at 5:04 PM
$RADX Good things come to people that wait.
0 · Reply
RadioIsotope25
RadioIsotope25 Jul. 5 at 9:21 PM
Radx’s Her2 lu-177 is potential $5 billion drug. $RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Jul. 4 at 1:35 PM
$RADX Up in Australia bottom is in.
1 · Reply
JoshThe3rd
JoshThe3rd Jul. 3 at 7:30 PM
$RADX chart w levels. Just a normal low vol drift IMO.
0 · Reply
neangewo
neangewo Jul. 3 at 4:50 PM
$RADX If this can’t hold $4 level, could be (more) trouble.
1 · Reply
RadioIsotope25
RadioIsotope25 Jul. 3 at 3:52 PM
100% upside $RADX
1 · Reply
RadioIsotope25
RadioIsotope25 Jul. 3 at 12:52 PM
$RADX Lantheus just bought more shares in Radiopharm Theranostics at $11.70… 7.50 upside to their buy price! Over their past 3 acquisitions they have paid $300 mil avg which implies 900% upside since market cap around $33 million. + major insider buying + tiny market cap + broad diversity in pipeline imaging and therapeutic isotopes + md anderson creating 4 new therapeutics for them + mid stage low risk brain imaging agent pivalate all signs it’s going well. + pdl-1 and her2 targeting therapeutics targeting huge billion dollar cancer markets lung cancer and breast. $INMB $LNTH
2 · Reply
RadioIsotope25
RadioIsotope25 Jul. 2 at 2:40 PM
$RADX If your trying to get in just buy at market. Market makers will usually let u in the stock in middle of bid ask.
0 · Reply
RadioIsotope25
RadioIsotope25 Jul. 2 at 2:23 AM
$RADX Good news ChatGPT likes nano bodies better than peptides for Lu-177 for targeting pdl1 and her2
0 · Reply
neangewo
neangewo Jul. 1 at 9:02 PM
$RADX I know the clinical prospects are good here and the tie up with Lantheus is great, but the price action sucks on this stock. The float is low and easily manipulated. All that said, why doesn’t Lantheus just swallow the company up at these bargain prices?
1 · Reply